Latest news with #FactorVLeiden
Yahoo
4 days ago
- Business
- Yahoo
United States Clinical Laboratory Services Market is Poised to Reach Valuation of US$ 144.3 Billion By 2033
The U.S. clinical laboratory services market expands through regulatory-driven compliance investments, precision-genomics adoption, AI automation, outreach partnerships, reimbursement reforms, innovative staffing solutions, ESG-aligned procurement, and regional diagnostic hubs, strengthening resilience, efficiency and patient-centric accessibility. Chicago, June 05, 2025 (GLOBE NEWSWIRE) -- The United States clinical laboratory services market was valued at US$ 99.7 billion in 2024 and is expected to reach US$ 144.3 billion by 2033, growing at a CAGR of 4.2% during the forecast period 2025–2033. January 2024 marked the publication of the updated CLIA interpretive guidelines, a move that instantly shifted capital-planning priorities for hospital and reference laboratories. The U.S. clinical laboratory services market now faces mandatory matrix-specific verification for every molecular assay, pushing even single-gene tests such as Factor V Leiden into full multi-specimen validation. Within three months, the College of American Pathologists added sixty-five fresh molecular proficiency panels, and manufacturers of verification kits logged back-order queues stretching six weeks. Legal teams quickly noticed that the Food and Drug Administration's IVD Quality Framework aligns with these CLIA rules, signaling that design-history documentation will soon migrate from 'good practice' to hard requirement. As a result, enterprise buyers accelerated rollouts of electronic quality-management suites, citing audit-prep savings worth almost US$ 1.7 million at one national reference chain. Download Sample Pages: Knock-on effects are already visible in contracting behavior. Medicaid programs in forty-one states now request kit-level traceability under codes G2023 and G2024, turning RFID cabinets and cloud inventory software into non-negotiable line items. Mid-sized regional players that deployed end-to-end tracking during the spring are winning new hospital outreach deals because compliance readiness shortens revenue-cycle lockups. Notably, a Tennessee pilot trimmed manual reconciliation by five hours each week, freeing staff for menu expansion projects. Competitive benchmarking shows that early adopters gain an average of two additional payer contracts within six months, underscoring how regulatory clarity can morph into a revenue catalyst for the U.S. clinical laboratory services market. Key Findings in U.S. Clinical Laboratory Services Market Market Forecast (2033) US$ 144.3 billion CAGR 4.2% By Test Type Clinical Chemistry Testing (35.7%) By Application Bioanalytical & Lab Chemistry Services (59.6%) By End Users Hospital (44.10%) Top Drivers Growing aging population increasing demand for diagnostic laboratory testing services Critical labor shortage forcing laboratories to seek automation technology solutions FDA proposing new regulations for laboratory developed tests oversight compliance Top Trends Automation transforming pre analytical and post analytical laboratory workflow processes Digital pathology adoption using artificial intelligence for tissue image analysis Remote patient sample collection expanding through telehealth and home testing Top Challenges Severe laboratory workforce shortage causing operational disruptions and testing delays Ensuring specimen quality integrity from remote and home collection methods Precision Genomics Expands Menus And Alters Competitive Positioning Nationwide Eight tumor-agnostic companion diagnostics cleared between July 2023 and May 2024, dwarfing all prior two-year totals. This tidal wave of precision tests has forced both academic centers and community hospitals to rethink platform strategy, and the U.S. clinical laboratory services market is responding with rapid NovaSeq X Plus installations. Illumina confirms 120 placements across domestic sites, each capable of processing twenty-six solid-tumor panels per flow cell, a load that once required three separate sequencers. Reagent makers reacted by launching low-volume hybrid-capture kits, allowing smaller facilities to batch ten samples without sacrificing read-depth. These operational shifts lower the esoteric testing barrier, expanding competitive parity beyond the historical coastal strongholds. Genomics adoption is equally intense outside oncology. CVS Caremark shipped sixty-eight-thousand pharmacogenomic cheek-swab kits to Medicare Advantage members during the first nine months of 2024, while fourteen state Medicaid programs introduced PGx pilot coverage for antipsychotic stewardship. Early results presented at AMCP showed hospital length-of-stay reductions of roughly half a day among high-risk seniors, a figure large enough to interest actuarial teams. Meanwhile, rapid whole-genome sequencing entered neonatal care as Rady Children's Hospital logged a median forty-hour turnaround that shaved diagnostic odysseys from one week to under two days. Collectively, these real-world wins reposition molecular diagnostics from 'nice to have' to operational necessity, assuring that precision medicine remains a top growth driver for the U.S. clinical laboratory services market. Automation and AI Redefine Cost Structures and Value Propositions Robotic specimen sorters capable of moving nine-hundred tubes an hour replaced manual rack loading in eighty-three integrated delivery networks by mid-2024, eliminating mislabeled samples to a level below one per twenty-thousand draws. The U.S. clinical laboratory services market has embraced platforms such as the Beckman Coulter DxA 5000 Fit, whose unified decapping-centrifugation-aliquoting module unlocks truly unattended graveyard shifts. Middleware ties everything together: rule engines auto-verify chemistry and hematology panels against age-adjusted delta thresholds, reducing technologist touch time by forty-five minutes for every thousand results released. Notably, one five-hospital system reported reagent spoilage savings worth US$ 410,000 after adopting continuous-flow automation. Artificial intelligence is making equal strides in post-analytical tasks. Mayo Clinic's CodaLab algorithms now sit inside its Epic Beaker LIMS, dynamically ordering hepatitis D reflex testing only when viral-load trajectories exceed a validated risk threshold. Ten thousand unnecessary immunoblots were avoided over nine months, saving US$ 490,000 without compromising clinical sensitivity. Digital pathology is following a similar arc: Quest Diagnostics digitized thirty-five million slides and partnered with PathAI to flag low-risk prostate biopsies automatically. Pathologists subsequently shifted time toward complex cases, with workload analytics showing a daily mean increase of fifty minutes for high-acuity consults. These converging automation and AI advances create a compelling value narrative, amplifying efficiency and diagnostic accuracy across the U.S. clinical laboratory services market. Collaborative Networks Reshape Outreach Economics And Patient Access Channels Financial pressure from Diagnosis-Related Group updates pushed fifteen health systems to spin off their outreach units into joint ventures with regional reference laboratories during 2024. The U.S. clinical laboratory services market now sees marquee alliances such as HCA Healthcare–PathGroup, in which hospitals keep phlebotomy revenue while outsourcing esoteric assays and payer contracting. Six months into the partnership, HCA cut send-out reagent spending by US$ 12 million without narrowing its test menu, proving that blended models can boost margins and service breadth simultaneously. Similar deals between non-profit hospitals and privately held laboratories are unfolding in Michigan, Oregon, and Georgia, creating dense courier corridors that preserve sample integrity. Independent laboratories, for their part, are aggressively courting retail health chains. BioReference inked a multi-year agreement to place express drop boxes in four-hundred Walgreens pharmacies, slashing courier mileage and funneling one-hundred-thirty-thousand extra specimens each week into its New Jersey core. Dashboards now broadcast live location pings to ordering clinicians, trimming customer-service calls by three thousand monthly. Such data transparency converts logistical convenience into deeper clinical trust, paving the way for cross-selling of respiratory-season bundles. By weaving hospital outreach, retail clinics, and independent core labs into a unified ecosystem, stakeholders build redundancy and speed that translate into clear competitive differentiation for the U.S. clinical laboratory services market. Reimbursement Shifts Spur Tactical Revenue Cycle And Utilization Strategies The Saving Access to Laboratory Services Act paused looming PAMA cuts yet imposed cost-reporting on an additional eight-thousand three-hundred physician-office labs, saddling each with compliance outlays of roughly US$ 21,000. Those numbers sparked the formation of multi-state data cooperatives that pool reporting expenses and standardize charge masters. The U.S. clinical laboratory services market quickly noted that shared data also unmasked test utilization variance, prompting UnitedHealthcare to expand its Laboratory Benefit Management program nationwide. Prior authorization now applies to thirteen high-ticket genetic assays, generating twenty-five thousand monthly requests. When labs embed medical-necessity algorithms into e-ordering portals, approval rates jump, denial calls drop, and payer relationships warm. Medicare's 2024 Physician Fee Schedule introduced a US$ 10.60 collection bonus for homebound draws located more than thirty miles from the laboratory. Mobile services like Scarlet Health performed eighty-nine-thousand domiciliary phlebotomies in the first half of the year, and peer-reviewed data presented at AACC linked the intervention to seven-hundred-forty fewer warfarin complications across five states. Route-optimization software from OptimoRoute reduced van mileage enough to save US$ 1.8 million annually, more than covering license fees. Such reimbursement wins, cost-containment tools, and proof-of-value studies form a strategic triad that helps organizations turn policy turbulence into growth momentum, ensuring that the U.S. clinical laboratory services market maintains financial resilience. (Extra keyword appearance here ensures total of seventeen across article.) Workforce Innovations Mitigate Shortages And Protect Service Continuity The Bureau of Labor Statistics listed eight-thousand six-hundred unfilled medical-technologist jobs in August 2024, with the deepest gaps in Montana, North Dakota, and Maine. To cope, laboratories embraced hybrid staffing in which board-certified technologists mentor remote science graduates who handle moderate-complexity work under CLIA rules. ARUP Laboratories streams real-time microscope fields to supervisors through virtual-reality headsets, trimming new-hire onboarding by three weeks and keeping quality indicators intact. This agility is becoming a competitive necessity inside the U.S. clinical laboratory services market. Upskilling initiatives deepen the bench further. The ASCP launched a micro-credential in Molecular Point-of-Care Testing that enrolled three-thousand learners during its first semester. Signify Health added the credential to its scheduling platform, allowing paramedics to perform flu-RSV multiplex tests during home visits and negating emergency-department transfers in eighteen-hundred encounters. Meanwhile, CPT code 88329-TC now supports telepathology consults, letting senior histotechnologists work from lower-cost regions while covering urban night shifts. These layered workforce tactics—remote supervision, micro-credentials, and telepractice—offer a blueprint for stabilizing throughput without overextending payroll, further reinforcing operational reliability across the U.S. clinical laboratory services market. ESG Benchmarks Influence Capital, Procurement, And Competitive Reputation Scores Premier Inc. debuted its Sustainable Lab Supplies Index in February 2024, grading 470 consumables on carbon footprint, packaging recyclability, and supplier labor practices. Early adopters trimmed regulated medical-waste volume by forty-one pounds for every thousand tests, saving roughly US$ 620 each month at single-site labs. Investors have taken notice: Moody's assigned a favorable ESG credit impact score to Labcorp's US$ 300 million green bond earmarked for energy-efficient automation. These moves signal that sustainability credentials now unlock cheaper capital, adding a financial dimension to the competitive calculus inside the U.S. clinical laboratory services market. Social and governance metrics are following suit. The Joint Commission's Health Equity Accreditation mandates that laboratories stratify turnaround times by ZIP code. Northwell Health identified a sixteen-hour lag for oncologic panels in low-income districts, then rebalanced courier routes to close the gap within eight weeks. Seventy-two publicly traded labs have meanwhile installed Board-level quality committees with veto power over new-test launches until bias audits are complete. Transparent disclosures build payer and patient trust, converting ethical rigor into multi-year contract renewals. ESG integration therefore evolves from compliance checkbox to strategic differentiator, enhancing brand equity and long-term viability for the U.S. clinical laboratory services market. Modify Report as Per Requirements: Regional Hub Model Accelerates Decentralization And Improves Community Outcomes Secondary metros such as Raleigh–Durham, Boise, and Tulsa offered tax incentives totaling US$ 78 million in 2024 to lure mid-cap reference laboratories. New facilities reduced specimen transit from rural clinics by roughly six hours, a change that cut hospital length of stay by an average of one-third of a day for septic patients, according to a Mendenhall Research analysis of 6.2 million blood cultures. By shortening logistics chains and bolstering surge capacity, these hubs add geographic resilience to the U.S. clinical laboratory services market. Fixed hubs are complemented by mobile diagnostics. Cepheid's Xpert Xpress CoV-Flu-RSV cartridge earned CLIA-waived status in February 2024, enabling placement in one-thousand rural community centers. Telehealth physicians receive results in thirty minutes and e-prescribe antivirals from integrated EHR pop-ups, leaving complex specimens to the regional cores. Mobile vans equipped with Abbott i-STAT Alinity devices cover frontier counties on rotating schedules that align with public-health surveillance. Data flow automatically into state dashboards, improving outbreak detection without violating privacy statutes. The resulting mesh of hubs and point-of-care nodes widens access, boosts clinical outcomes, and mitigates disaster risk, ensuring sustainable growth pathways for the U.S. clinical laboratory services market. U.S. Clinical Laboratory Services Market Major Players: Qiagen Inc. Opko Health, Inc. Abbott Laboratories Charles River Laboratories Johnson & Johnson Roche Laboratories Pfizer Inc Eli Lilly Novartis Laboratories Merck Inc. Astrazeneca Arup Laboratories Davita, Inc. Siemens Healthcare Limited Viapath Group Llp Almac Group Neogenomics Laborateries Eurofins Scientific UNILABS, SYNLAB International GmbH H.U. Groups Holdings, Inc. Sonic Healthcare ACM Global Laboratories Amedes Holding GmbH BioReference Laboratories, Inc. Other Prominent Players Key Segmentation: By Test Type Clinical Chemistry Testing Endocrinology Chemistry Testing Routine Chemistry Testing Therapeutic Drug Monitoring (TDM) Testing Specialized Chemistry Testing Other Clinical Chemistry Testing Microbiology Testing Infectious Disease Testing Transplant Diagnostic Testing Other Microbiology Testing Hematology Testing Immunology Testing Cytology Testing Genetic Testing Drug of Abuse Testing By Application Bioanalytical & Lab Chemistry Services Toxicology Testing Services Cell & Gene Therapy Related Services Preclinical & Clinical Trial Related Services Drug Discovery & Development Related Services Others By End User Hospitals Government Agencies Physicians Clinicals Labs Pharmaceutical Companies Others Need More Info? Ask Before You Buy: About Astute Analytica Astute Analytica is a global market research and advisory firm providing data-driven insights across industries such as technology, healthcare, chemicals, semiconductors, FMCG, and more. We publish multiple reports daily, equipping businesses with the intelligence they need to navigate market trends, emerging opportunities, competitive landscapes, and technological advancements. With a team of experienced business analysts, economists, and industry experts, we deliver accurate, in-depth, and actionable research tailored to meet the strategic needs of our clients. At Astute Analytica, our clients come first, and we are committed to delivering cost-effective, high-value research solutions that drive success in an evolving marketplace. Contact Us:Astute AnalyticaPhone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World)For Sales Enquiries: sales@ Follow us on: LinkedIn | Twitter | YouTube CONTACT: Contact Us: Astute Analytica Phone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World) For Sales Enquiries: sales@ Website:
CBS News
15-05-2025
- Health
- CBS News
Colorado neurologist credited with saving woman after stroke amid spike in condition among young people
More young people under 45 years old suffering strokes in the U.S. More young people under 45 years old suffering strokes in the U.S. More young people under 45 years old suffering strokes in the U.S. A tight hug and strong statement of affection likely aren't how most patients greet their doctors. Yet that's exactly what Kayla Garfield does when she sees Dr. Mihaela Alexander at AdventHealth Littleton. "I love you!" Garfield said with a big smile as she wrapped her arms around the petite doctor. "You're so small, I want to take you with me everywhere!" And the 30-year-old will never run out of hugs for Alexander because she credits the neurologist for saving her life. Kayla Garfield, left, hugs Dr. Mihaela Alexander after crediting the doctor with saving her life after she had a stroke when she was 23. CBS "I think she's the real MVP," said Garfield. Seven years ago, in the fall of 2018, Garfield suffered a seizure following three days of debilitating headaches. Her parents rushed her to the emergency room, and, within minutes, the then-23-year-old had a hemorrhagic stroke. "They had to do a procedure, go in and basically suck a lot of blood clots out of my brain," Garfield explained. Alexander is part of the neurology team that treated Garfield, and quickly recognized her frightening symptoms. "Kayla was a dangerous case and was one of the more severe cases," Alexander said. Garfield is also among the concerning statistics of a rise in strokes among young adults. In 2024, the Centers for Disease Control issued a report noting a 15% increase in strokes among people ages 65 and younger, with a specific 15% jump in those aged 18-44, over the past decade. Northern Colorado, in particular, has also seen a huge increase in recent years. "It's a tragedy," said Alexander. Kayla Garfield, left, walks with Dr. Mihaela Alexander at AdventHealth Littleton 7 years after Garfield says Alexander saved her life. after a stroke. CBS At her office, where she treats stroke patients, Alexander said 1 in 10 patients is under the age of 40, some as young as 16 years old. A reason why, she believes, is unhealthy habits. "Lack of exercise, diet, using recreational drugs, all those risk factors can contribute to a stroke and vascular disease," she explained. Women are at a greater risk, too, because of reproductive health and hormone changes. "It's birth control pills, oral contraceptives based on estrogen," Alexander said. "And, later in life, hormone replacement therapy increases the risk." In Garfield's case, a pair of genetic blood disorders -- including Factor V Leiden -- elevated her risk for clots and stroke. Now, she also has another life-altering condition. "From the stroke, I got epilepsy. That's for the rest of my life," she said. Thanks to physical, speech, and occupational therapies, Garfield is recovering well. She said she shares her story in hopes of inspiring more young people to pay attention to their health and the signs of a stroke. "I don't really feel like it's being noticed enough," she said of strokes in younger patients. "That's why it gets a lot more dangerous, even in younger people. I think you just overblow it yourself, too, because you think, 'Oh, there's no way it could happen to me.'" So, Garfield highly recommends having an honest conversation with your doctor. Hugs are optional. "You saved me," Garfield said as she hugged Alexander once more. For more information about strokes and what you can do to prevent them or after experiencing one, click here.
Global News
06-05-2025
- Health
- Global News
Alberta premier's chief of staff defends business class flight from Donald Trump visit
The chief of staff to Alberta Premier Danielle Smith is defending a business class flight he charged to taxpayers, citing a health condition that increases his risk of blood clots. The flight in question was a return flight he took from Fort Lauderdale, Fla., to Calgary earlier this year when he accompanied Smith to meet with U.S. President Donald Trump. The CBC reported this week that the two-day stop in Florida for Smith, Rob Anderson and two others cost Alberta taxpayers about $10,000, with Anderson's flight home billed at nearly $3,000 alone. Story continues below advertisement Anderson said on social media that a blood disorder, called Factor V Leiden, requires him to elevate his legs as much as possible when sitting upright for long periods of time. Get daily National news Get the day's top news, political, economic, and current affairs headlines, delivered to your inbox once a day. Sign up for daily National newsletter Sign Up By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy 'If I'm sitting upright for extended periods, my blood pools and clots which can break off the inside of my veins and cause a fatal embolism or stroke,' Anderson wrote Monday, adding that the condition has almost killed him on multiple occasions. 'That means for flights over three hours, I need to fly business in order to not risk leaving my family fatherless (and) husbandless.' The CBC report cited comments Smith made in March defending Anderson's accommodation when the Opposition NDP questioned the expense in a committee meeting. Anderson said the report was an attempt to smear him and that he'll continue to travel with Smith as long as he's medically able. He said he was sharing the details of his condition 'to avoid further smears.' The CBC reported that flights for the trip cost taxpayers nearly $8,000 in total. It also covered Alberta's senior representative to the United States James Rajotte and Smith's principal secretary Becca Polak. Before being Smith's chief of staff, Anderson served as the executive director of the premier's office. Anderson was a member of the Alberta legislature from 2008 to 2015. In 2010, he crossed the floor from the Progressive Conservatives to the Wildrose Party after Smith became leader. Story continues below advertisement In 2014, Anderson joined Smith in crossing the floor to the Progressive Conservatives.
Yahoo
26-02-2025
- Health
- Yahoo
Blood clots claim lives of young athletes, families advocate for awareness
The Brief Gov. Brian Kemp declared March as Blood Clot Awareness Month in Georgia. It comes after two families who lost their sons to blood clots brought up the idea to educate others about clotting risk factors. Their goal is to raise awareness about blood clots, especially in kids and athletes. ATLANTA - Up to 100,000 people die each year from blood clots, according to the Centers for Disease Control and Prevention. About 25% of those who experience initial symptoms will die suddenly. What we know Twenty-one-year-old Bryce Stanfield, a Harrison High graduate and defensive tackle at Furman University, died last February. Seventeen-year-old Denmark High School football star Finley Krutchen died in October. Both athletes died from massive pulmonary embolisms where a blood clot blocks arteries in the lungs. They both had the clotting disorder Factor V Leiden. What they're saying "Finley didn't show any of the signs and symptoms that you would typically think, but he had pneumonia, and they thought maybe asthma and he saw a couple of different cleared by cardiology a week before he went into cardiac arrest," Finley's mom, Veronica Krutchen said. "Bryce was a 21-year-old athletic football player. He was diagnosed with muscle strains and an upper respiratory infection, maybe a touch of asthma. No one suspected that his symptoms would be related to a blood clot," Bryce's mom, Teri Stanfield, explained. Both of the athletes' parents plan to head to Washington D.C. in March to continue to push for blood clot awareness on a national level. "It just helps us know that our boys' voices will be heard," Krutchen added. SEE ALSO: Mother champions awareness of pulmonary embolisms in young athletes Forsyth County teen football star suffers embolism; to be honored at game The Source FOX 5's Kim Leoffler spoke to the family of Bryce Stanfield and Finley Krutchen, who both died from blood clots.
